A comparison of oral cefuroxime axetil and oral amoxycillin in lower respiratory tract infections. 1985

T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd

We assessed oral cefuroxime axetil in an open study of 30 patients with lower respiratory tract infection and then compared oral cefuroxime with oral amoxycillin in a randomized double blind study in a further 40 patients. Satisfactory clinical responses were obtained in 73% of patients receiving cefuroxime axetil 500 mg tid in the open study, and in the comparative study in 71% of patients receiving cefuroxime axetil 500 mg bd, in 60% of patients receiving cefuroxime axetil 500 mg tid and in 63% of patients receiving amoxycillin 500 mg tid. There were no significant differences in response rates between the three regimens in the comparative study. There were no important adverse effects in any of the patients. Oral cefuroxime axetil is safe and effective in the therapy of lower respiratory tract infections.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010366 Peak Expiratory Flow Rate Measurement of the maximum rate of airflow attained during a FORCED VITAL CAPACITY determination. Common abbreviations are PEFR and PFR. Expiratory Peak Flow Rate,Flow Rate, Peak Expiratory,PEFR
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002444 Cefuroxime Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. Cephuroxime,Ketocef,Zinacef
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000658 Amoxicillin A broad-spectrum semisynthetic antibiotic similar to AMPICILLIN except that its resistance to gastric acid permits higher serum levels with oral administration. Hydroxyampicillin,Actimoxi,Amoxicillin Anhydrous,Amoxicillin Monopotassium Salt,Amoxicillin Monosodium Salt,Amoxicillin Sodium,Amoxicillin Trihydrate,Amoxicillin, (R*)-Isomer,Amoxicilline,Amoxil,Amoxycillin,BRL-2333,Clamoxyl,Clamoxyl G.A.,Clamoxyl Parenteral,Penamox,Polymox,Trimox,Wymox,BRL 2333,BRL2333

Related Publications

T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
July 1989, Journal of chemotherapy (Florence, Italy),
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
January 1990, Clinical therapeutics,
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
January 1988, Therapie,
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
February 1992, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
March 1996, The Journal of antimicrobial chemotherapy,
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
May 1992, Anales de medicina interna (Madrid, Spain : 1984),
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
July 1989, Journal of chemotherapy (Florence, Italy),
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
January 1987, Drugs under experimental and clinical research,
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
January 1987, Current medical research and opinion,
T J Cooper, and E Ladusans, and P E Williams, and V Polychronopoulos, and H Gaya, and R M Rudd
February 1988, Archives of internal medicine,
Copied contents to your clipboard!